Targeting the epidermal growth factor receptor by erlotinib (Tarceva) for the treatment of esophageal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16217753

Int. J. Cancer 2006 Apr 1 118 7 1814-22

Download in:

View as

General Info

PMID
16217753